Introduction
Early-onset dementia (EOD), defined as the onset of symptoms before the age of 65, presents a unique set of clinical challenges compared to late-onset dementia (LOD). While Alzheimer’s Disease (AD) is the most recognized form of cognitive decline in younger populations, Dementia with Lewy Bodies (DLB) is the second most common neurodegenerative dementia. Despite its prevalence, the clinical profile of early-onset DLB (EODLB) is frequently misunderstood, leading to suboptimal diagnosis rates that hinder effective treatment and patient outcomes.
This study addresses the diagnostic gap by hypothesizing that EODLB possesses a distinct clinical and neuropsychiatric profile compared to early-onset Alzheimer’s Disease (EOAD). By utilizing pathologically confirmed data, the research aims to identify the specific markers that can help clinicians differentiate these two conditions more accurately.
Methods
The researchers conducted a retrospective analysis using data from the National Alzheimer’s Coordinating Center (NACC) database, a comprehensive longitudinal dataset aggregated from NIA-funded Alzheimer’s Disease Centers across the United States.
To ensure the highest level of diagnostic accuracy, the study focused on patients with pathologically confirmed diagnoses rather than clinical impressions alone. The cohort included 363 patients with EOAD, 32 with EODLB, and 147 with late-onset DLB (LODLB). The analysis compared baseline demographics, cognitive performance (via neuropsychological battery scores), behavioral symptoms, and motor symptoms across three groups: EODLB versus EOAD, and EODLB versus LODLB.
The Diagnostic Gap: A High Rate of Misidentification
One of the most striking findings of the study is the high rate of clinical misdiagnosis. Nearly half of the patients with pathologically confirmed EODLB (46.9%) were initially misdiagnosed as having EOAD ($p < 0.0001$).
This discrepancy suggests that current diagnostic frameworks, which are often heavily weighted toward memory and executive function, are insufficient for identifying DLB in younger patients. Because EOAD is the "default" diagnosis for early-onset cognitive decline, the specific motor and psychiatric markers of DLB are frequently overlooked or attributed to other causes.
Clinical Profiles: EODLB vs. EOAD
The study identified several key clinical features that distinguish EODLB from EOAD. While EOAD patients typically present with memory impairment as their primary and most prominent symptom, EODLB patients exhibit a more diverse range of symptoms at onset:
- Motor Symptoms: EODLB patients were significantly more likely to present with motor symptoms—such as physical slowness (bradykinesia) and tremors—as their first recognized sign of illness.
- Neuropsychiatric Markers: Psychosis, apathy, and REM sleep behavioral disorder (RBD) were significantly more prevalent in the EODLB group.
- Caregiver Observations: Caregiver reports of agitation and apathy were found to be significant predictors in differentiating EODLB from EOAD.
- Cognitive Performance: Interestingly, neuropsychological tests were found to be less reliable for differentiation. While EOAD patients generally performed worse on memory-specific assessments, both groups showed overlapping deficits in other cognitive domains, making standard cognitive testing a weak tool for definitive diagnosis in early-onset cases.
Age-Related Phenotypes: EODLB vs. LODLB
The research also highlighted that EODLB is not simply a younger version of the late-onset disease. When comparing EODLB to LODLB, several differences emerged:
- Mood and Cognition: EODLB patients were found to be more depressed than their late-onset counterparts.
- Cognitive Preservation: Despite their psychiatric symptoms, EODLB patients actually performed better on memory and executive function tests than LODLB patients, suggesting that the cognitive trajectory of DLB may be slower or different in younger brains.
Conclusion and Clinical Implications
The high rate of misdiagnosis (46.9%) for EODLB underscores an urgent need for a more comprehensive clinical approach. The study suggests that clinicians should move beyond a memory-centric diagnostic model when evaluating younger patients.
To improve diagnostic accuracy, clinicians should prioritize the evaluation of:
- Motor function, specifically looking for bradykinesia.
- Sleep history, with a focus on REM sleep behavioral disorder.
- Neuropsychiatric symptoms, including visual hallucinations and apathy.
By integrating these markers into the initial assessment, the medical community can improve the detection of EODLB, ensuring that patients receive appropriate management for their specific symptoms and pathology. Future research should focus on developing screening tools tailored to younger populations that emphasize these non-cognitive markers.
Summary updated